✦ LIBER ✦

“Real World” Treatment of Metastatic Renal Cell Carcinoma in a Joint Community-Academic Cohort: Progression-Free Survival Over Three Lines of Therapy

✍ Scribed by Harrison, Michael R.; George, Daniel J.; Walker, Mark S.; Chen, Connie; Korytowsky, Beata; Kirkendall, Donald T.; Stepanski, Edward J.; Abernethy, Amy P.

Book ID: 122092773
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 767 KB
Volume: 11
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2013.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment Patterns: Targeted Therapies I

Treatment Patterns: Targeted Therapies Indicated for First-Line Management of Metastatic Renal Cell Carcinoma in a Real-World Setting

✍ Hess, Gregory; Borker, Rohit; Fonseca, Eileen 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 276 KB

4518 POSTER First-line bevacizumab impro

4518 POSTER First-line bevacizumab improves progression-free survival with lower doses of interferon-a2a in the treatment of patients with metastatic renal cell carcinoma (AVOREN)

✍ Melichar, B.; Koralewski, P.; Pluzanska, A.; Ravaud, A.; Bracarda, S.; Szczylik, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 67 KB

4008 POSTER Bevacizumab/interferon-alpha

4008 POSTER Bevacizumab/interferon-alpha2a provides a progression-free survival benefit in all prespecified patient subgroups as first-line treatment of metastatic renal cell carcinoma (AVOREN)

✍ S. Bracarda; P. Koralewski; A. Pluzanska; A. Ravaud; C. Szczylik; C. Chevreau; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

94 A REAL-LIFE COMPARATIVE EFFECTIVENESS

94 A REAL-LIFE COMPARATIVE EFFECTIVENESS SIMULATION OF PROGRESSION FREE SURVIVAL COMPARING FIRST-LINE SUNITINIB VS. BEVACIZUMAB + INTERFERON-ALPHA 2A IN METASTATIC RENAL CELL CARCINOMA-CONSIDERING THE EFFECTS OF DOWN-DOSING AND PATIENT COMPLIANCE

✍ G.H. Mickisch; B. Schwander; B. Escudier; J. Bellmunt; J.P. Maroto; C. Porta; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB